Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I Disorder [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing topiramate to placebo in bipolar disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Bipolar Disorder, Affective Disorders, Psychotic | Phase 3 | Status: COMPLETED